Page 22 - AIH-1-3
P. 22

Artificial Intelligence in Health                                           Optimizing EHRs to support AI



            collection of data points to determine if a pattern exists, or   of health information from citizen demographic or
            for algorithm development to make decisions or support   identification data by adopting a privacy-by-design
            decision-making or make predictions. Training any AI   approach. Every citizen needs to have control over
            model requires large amounts of representative data. The   their data and how it is used.
            number and types of accessible data points determine the   (3)  Facilitate the linkage of health-care data with omics
            accuracy of the model or a possible set of rules that can   data, that is with the inclusion of data representing
            be identified. The delivery of health services is data centric   the various “omes” of an organism, to enable making
            where access to accurate and timely data is critical for   sense of vast amounts of collected data to build
            decision-making. AI approaches making use of these data   next  generations of  clinical decision support and
            require the use of advanced analytics and access of a large   research methods and tools. At present, the use of
            amount of source data. Data-driven approaches are relevant   genetic sequencing and variation information is not
            for the provision of automated reporting as automation   part of routine clinical practice because health-care
                                                    58
            relies on pre-determined rules or assumptions.  There   professionals do not have the knowledge or skills.
            are significant limitations regarding access to source data   Most importantly, there is a lack of automated tools
            collected and stored in legacy systems.               that can reliably associate phenotypic data from EHRs
                                                                  with many types of omics data to provide personal
            4. New and emerging technologies                      and precision care. Large-scale, well-annotated, and

            This review’s findings have confirmed that the interoperable   high-quality EHR data will have an immense impact
            and scalable ecosystem-wide architectures can be adopted,   on bringing omics and healthcare together.
            the knowledge about the health ecosystem’s data supply   (4)  Facilitate the linkage of healthcare and data with
            chain, and the relationships between information models,   the human physiome 59,60  comprising personal and
            terminologies, and ontologies with data exchange protocols.   mechanistic computational multi-scale models. Such
            Health ecosystem-wide data supply chains need to:     models enable the provision of new types of insight
            (1)  Include  data/information flow  requirements to   into not only our understanding of human physiology
               support collaborative, person-centered life-long, and   and pathology but also predictions of disease and
               episodic continuity of care. Episodic events of multiple   prognosis. Such insights are the result of using
               service episodes can also exist. Such episodes represent   ontology-based EHR data linkage that parameterize
               a treatment plan for one specific health issue such as   these models that are able to run surprisingly reliable
               for cancer care or a pregnancy as recorded by multiple   simulations at individual or population levels.
               systems over a period of time. Data collections able   Computational physiology and systems biology
               to meet all information needs associated with any   provide us with unprecedented precision to provide
               treatment/care plan require identifiable data transfers   value-based  and  appropriate  care  as  well  as  drive
               between any number of individual and organizational   more effective drug and medical device development
               health-care service providers as well as devices.   and faster compliance through in silico medicine and
                                                                             61
               Specific data needs will differ based on the individual’s   clinical trials.
               health status, treatment/care plans (life-long and   Data governance protocols, legislation, and regulations
               episodic), and geographical location relative to service   need to facilitate or enable these requirements to deliver
               availability at any point in time.              optimal benefits of data use, including any type of effective
            (2)  Facilitate the aggregation of de-identified data and   reporting automation and AI adoption.
               identifiable data to classify any number of grouping
               protocols (populations) or individuals to suit specific   4.1. Next-generation EHR/EMR system
               data use cases. Data relationships will vary by use   characteristics
               case and need to include data from systems other   Next-generation  EHR/EMR  systems  are  designed  to
               than data collected and stored by EHR/EMRs, such   reduce or eliminate these gaps and improve the generation
               as clinical registries. Over time, such registries are   of quality data within a connected digital health ecosystem.
               expected to be generated from vendor/technology-  New health platforms need to be engineered to integrate
               neutral federated cloud-based health data repositories   personal health information received from emerging
               including CDRs. For some use cases, linkages may   technologies in the fields of personal health and well-being,
               also need to include relationships between weather   including  apps  and wearables.  EHR/EMR  systems  and
               events or environmental status at a specific point in   CDRs should become a valuable computable data source
               time or by geographical location, such as vaccination   for research and evaluation purposes as well as be enriched
               rates. CDR design needs to prioritize the separation   by data from external data sources while complying with


            Volume 1 Issue 3 (2024)                         16                               doi: 10.36922/aih.3056
   17   18   19   20   21   22   23   24   25   26   27